SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Allianz SE - ALIZF

New York, New York--(Newsfile Corp. - May 19, 2022) - Pomerantz LLP is investigating claims on behalf of investors of Allianz SE ("Allianz" or the "Company") (OTC Pink: ALIZF). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.

The investigation concerns whether Allianz and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

[Click here for information about joining the class action]

On August 1, 2021, Allianz disclosed that "the U.S. Department of Justice ('DOJ') has begun an investigation concerning the Structured Alpha Funds," and that "there is a relevant risk that the matters relating to the Structured Alpha Funds could materially impact future financial results of Allianz Group."

On this news, Allianz's stock price fell $2.00 per share, or 8%, to close at $22.85 per share on August 2, 2021.

Then, on May 17, 2022, Allianz pleaded guilty to securities fraud, admitting that it lacked internal controls and oversight for a series of private-investment funds and made false and misleading statements to investors. The Company agreed to pay $6 billion in penalties and restitution.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

CONTACT:
Robert S. Willoughby
Pomerantz LLP
rswilloughby@pomlaw.com
888-476-6529 ext. 7980

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/124728

info